BridgeMD
Tests treatment safety and results for Diarrhea-predominant Irritable Bowel Syndrome
Official title Evaluation of the Efficacy and Safety of Gelsectan in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome
ClinicalTrials.gov ID: NCT07000383
What this study is testing
What is Antispasmodic Agent?
Antispasmodic Agent is an investigational medicine, given as an once-daily infusion into a vein, being studied as a potential treatment for diarrhea-predominant irritable bowel syndrome.
Also referred to as Antispasmodic drug.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This clinical study aims to investigate the effectiveness and safety of Gelsectan, a treatment containing xyloglucan, in adults diagnosed with diarrhea-predominant irritable bowel syndrome (IBS-D) in Vietnam. IBS-D is a common digestive disorder that causes frequent diarrhea along with abdominal pain and bloating, significantly affecting patients' daily life and wellbeing.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥ 18 years
- Diagnosis of IBS-D based on the Rome IV criteria,8 including:
- Recurrent abdominal pain occurring at least one day per week in the last three months, associated with at least two of the following: related to...
- More than 25% of bowel movements with stool types 6 or 7 and less than 25% with stool types 1 or 2 according to the Bristol Stool Form Scale.
- Signed informed consent for study participation
You likely can't join if
- Pregnant or breastfeeding women
- Known allergy to any component of the study medication
- Diagnosed with diabetes mellitus
- Patients with severe comorbidities or psychiatric disorders that impair their ability to complete questionnaires or attend follow-up visits
The study team makes the final eligibility decision.
Where it's taking place
- Ho Chi Minh City, District 5, Vietnam
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ho Chi Minh City, District 5, Vietnam. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.